Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214123 · ClinicalTrials.gov registry record · Phase 1
Hypofractionated Radiotherapy for Lung Cancer
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 1
- Development phase
- 79
- Enrollment target
NCT00214123 is a Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 79 participants.
The verdict
NCT00214123, a Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this trial is to pilot reducing the duration of radiation treatment for lung cancer patients from 6 to 5 weeks using tomotherapy. Specific patient doses will be based on tumor volume being treated. Modeling has shown that increased biologically effective dose (BED) to tumors can be achieved by shortening the radiation delivery schedule and increasing the dose per fraction. This requires decreasing the total dose to hold lung toxicity constant at each dose per fraction level. This is a major paradigm shift in the treatment in this disease and is projected to result in significant improvements in patient outcome as well as a substantial cost savings.
Interventions
- RADIATION radiation therapy (radiotherapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2004-06 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00214123
The ClinicalTrials.gov registry entry for NCT00214123 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which radiation therapy (radiotherapy) is the first listed.
NCT00214123 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00214123 about?
NCT00214123 is a clinical study titled "Hypofractionated Radiotherapy for Lung Cancer". The purpose of this trial is to pilot reducing the duration of radiation treatment for lung cancer patients from 6 to 5 weeks using tomotherapy. Specific patient doses will be based on tumor volume being treated. Modeling has shown that increased biologically effective dose (BED) to tumors can be ac...
What is the current status of trial NCT00214123?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 79 participants. The study started on 2004-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00214123?
The interventions under investigation include: radiation therapy (radiotherapy) (RADIATION).
Who is sponsoring clinical trial NCT00214123?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.